Gemfibrozil clinical trials
Also written Lopid and PLX-200.
How each study uses Gemfibrozil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Gemfibrozil studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 21 Dec 1981 · LOPID · NDA 018422 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
13 studies that test it; most in 2014 (2); 1 more planned to start later
| Year | Studies |
|---|---|
| 1991 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 6
Polaryx Therapeutics, Inc. (2) · Actelion (1) · Gregory Jicha, 323-5550 (1) · University of Texas Southwestern Medical Center (1) · Eli Lilly and Company (1) · GlaxoSmithKline (1) · Centre for Addiction and Mental Health (1) · VA Office of Research and Development (1)
Often tested with
Tested in the same studies.
Selexipag (1) · Rifampin (1) · Evacetrapib (1) · GSK1278863 (1)
Related medicines
As reviewed, each with the page that says it.
- One of Hypolipidemic Agents source
Studies
Open first, then newest update. How each study uses Gemfibrozil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 14
- Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PLX-200 in Pediatric Patients (Master Protocol)Not yet recruitingPhase 2Polaryx Therapeutics, Inc.NCT07740512Written as PLX-200
- Safety, Tolerability, and Efficacy of PLX-200 in Patients With CLN3WithdrawnPhase 3Polaryx Therapeutics, Inc.NCT04637282Written as PLX-200
- Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients.WithdrawnPhase 2Forest Hills LabNCT05931484Written as Gemfibrozil
- A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy SubjectsCompletedPhase 1ActelionNCT02770222Written as Gemfibrozil
- Exploration of Gemfibrozil as a Treatment for AUDTerminatedPhase 2The Mind Research NetworkNCT03539432Written as Gemfibrozil 600 MG
- Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer DiseaseCompletedEarly Phase 1Gregory Jicha, 323-5550NCT02045056Written as Gemfibrozil
- Gemfibrozil for Nicotine Smoking CessationCompletedPhase 2University of Texas Southwestern Medical CenterNCT02638597Written as Gemfibrozil
- A Study of Evacetrapib in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT01736254Written as Gemfibrozil
- Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil)CompletedPhase 1GlaxoSmithKlineNCT01376232Written as Gemfibrozil
- Initial Screening of Gemfibrozil as a Novel Treatment for Tobacco AddictionCompletedPhase 2Centre for Addiction and Mental HealthNCT01876810Written as Gemfibrozil
- The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-CholesterolCompletedPhase 3VA Office of Research and DevelopmentNCT00283335Written as gemfibrozil
- Bioequivalence Study Between Two Oral Formulations of Gemfibrozil TabletsCompletedPhase 1Blu CaribeNCT00800475Written as Gemfibrozil Tablets
- Drug-Drug Interaction Study of Mitiglinide and GemfibrozilCompletedPhase 1Elixir PharmaceuticalsNCT00566865Written as gemfibrozil
- Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and TriglyceridesCompletedPhase 1US Department of Veterans AffairsNCT00108511Written as Gemfibrozil
Given beside what is tested · 15 — Gemfibrozil is usual care or a partner of the new treatment
- A Study Investigating the Effect of Different Approved Medications on How the Body Processes the Study Compound RO7795081CompletedPhase 1Hoffmann-La RocheNCT06809608Written as Gemfibrozil
- Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult SubjectsCompletedPhase 1SanofiNCT06064539Written as gemfibrozil
- Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and CamlipixantCompletedPhase 1Bellus Health Inc. - a GSK companyNCT05959447Written as Gemfibrozil
- A Phase 1, Open-label Study Evaluating the Pharmacokinetics and Drug-drug Interaction of VX-993 in Healthy AdultsCompletedPhase 1Vertex Pharmaceuticals IncorporatedNCT06392659Written as Gemfibrozil
- A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT05932303Written as Gemfibrozil
- A Study to Assess the Effect of Itraconazole, Phenytoin and Gemfibrozil on the Drug Levels of BMS-986166 in Healthy ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT04956627Written as Gemfibrozil
- A Study to Investigate the Drug-drug Interactions (DDIs) of SKLB1028 With Itraconazole, Gemfibrozil or Rifampicin in Healthy SubjectsStatus unknownPhase 1CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT05069870Written as Gemfibrozil
- The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the BloodstreamCompletedPhase 1Eli Lilly and CompanyNCT01836198Written as Gemfibrozil
- A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid TumorsCompletedPhase 1GlaxoSmithKlineNCT01340846Written as Gemfibrozil
- Study to Assess Drug-Drug Interaction Between Itraconazole or Gemfibrozil and JNJ-56021927CompletedPhase 1Aragon Pharmaceuticals, Inc.NCT02230033Written as Gemfibrozil
- Relative Bioavailability of Single Dose Empagliflozin (BI 10773) When Co-administered With Multiple Doses of 600 mg Gemfibrozil Compared to Single Dose Treatment With Empagliflozin (BI 10773) When Given Alone in Healthy VolunteersCompletedPhase 1Boehringer IngelheimNCT01301742Written as Gemfibrozil
- Drug-drug Interaction Study With MDV3100 (ASP9785) and Gemfibrozil and ItraconazoleCompletedPhase 1Astellas Pharma Europe B.V.NCT01913379Written as Gemfibrozil
- A Study to Assess the Effect of Multiple Doses of Gemfribozil on a Single Dose of ASP3652, and to Assess the Effects of Multiple Doses of ASP3652 on a Single Dose of Repaglinide in the Body of Healthy SubjectsCompletedPhase 1Astellas Pharma Europe B.V.NCT01797198Written as Gemfibrozil
- Study Evaluating Potential Interaction Between SAM-531 And Gemfibrozil When Co-AdministeredCompletedPhase 1Wyeth is now a wholly owned subsidiary of PfizerNCT00966966Written as SAM-531 and gemfibrozil
- To Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656CompletedPhase 1AstraZenecaNCT01083212Written as Gemfibrozil
Codes
What other systems call Gemfibrozil · ClinicalTrials.gg INT008450
- MeSH (NLM) D015248GemfibrozilConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) Q8X02027X3GEMFIBROZILConfirmed FDA, NLM, Wikidata
- RxNorm 4719Confirmed FDA, Wikidata
- Wikidata Q384295gemfibrozilConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29071GemfibrozilOne source FDA
- DrugBank DB01241One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D015248 | Gemfibrozil | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | Q8X02027X3 | GEMFIBROZIL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 4719 | — | Confirmed FDA, Wikidata |
| Wikidata | Q384295 | gemfibrozil | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29071 | Gemfibrozil | One source FDA |
| DrugBank | DB01241 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.